Skip to main content
Arctic Bioscience logo

Arctic Bioscience — Investor Relations & Filings

Ticker · ABS ISIN · NO0010859580 LEI · 549300Z2HW6I989Q2C78 OL Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2024-10-18 Director's Dealing
Country NO Norway
Listing OL ABS

About Arctic Bioscience

https://arctic-bioscience.com/

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is structured as a formal notification template concerning transactions by persons discharging managerial responsibilities (PDMRs). Specifically, it details a 'Share Sale' by an entity closely associated with a 'Board member' of 'Arctic Bioscience AS'. This structure and content directly correspond to insider trading disclosure requirements, which mandate reporting personal share transactions by directors and executives. This aligns perfectly with the definition for Director's Dealing (DIRS).
2024-10-18 English
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 100% confidence The document is structured as a formal notification template concerning transactions by persons discharging managerial responsibilities (PDMRs). Specifically, it details a 'Share Sale' by an entity closely associated with a 'Board member' of 'Arctic Bioscience AS'. This structure and content directly correspond to insider trading disclosure requirements, which mandate reporting personal share transactions by directors and executives. This aligns perfectly with the definition for Director's Dealing (DIRS).
2024-10-18 English
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is titled 'Arctic Bioscience - Mandatory notification of trade' and explicitly details a sale of shares by an entity closely associated with a person discharging managerial responsibility (a Board Member/CEO). This transaction disclosure is mandated under Regulation EU 596/2014 (MAR) article 19, which governs insider trading notifications. This directly corresponds to the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is short (1703 chars) and mentions an 'attached notification,' but the core content is the insider trade disclosure itself, making DIRS a more specific fit than RPA or RNS.
2024-10-18 English
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 98% confidence The document text is titled "Arctic Bioscience - Meldepliktig handel" (Mandatory Trading Notification) and details a transaction where a related party (Eggesbø Eiendom AS) sold shares of Arctic Bioscience. It explicitly mentions that the information is subject to MAR (Market Abuse Regulation) Article 19 and the Norwegian Securities Trading Act § 5-12, which mandates reporting of insider transactions by persons discharging managerial responsibilities (PDMRs). This directly corresponds to the definition of Director's Dealing (insider trades). The document is a notification of a specific transaction by an insider, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the core transaction details itself. Therefore, the appropriate code is DIRS.
2024-10-18 Norwegian
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 100% confidence The document text is explicitly titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a transaction (Share Purchase) by an individual (Daniele Mancinelli, CTO) involving the company's common shares, including price, volume, and date. This structure perfectly matches the definition of a Director's Dealing report, which tracks personal share transactions by executives and directors.
2024-10-18 English
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document text is explicitly titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a transaction (Share Purchase) by an individual (Daniele Mancinelli, CTO) involving the company's common shares, including price, volume, and date. This structure perfectly matches the definition of a Director's Dealing report, which tracks personal share transactions by executives and directors.
2024-10-18 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.